Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

------------------------------------------------------------

June 19, 2002

INTERNATIONAL IMMUNIZATION NEWS

"Carlsbad, Calif., Biotechnology Firm Expects Thailand to Approve Vaccine" San Diego Union-Tribune (www.uniontrib.com) (06/18/02); Crabtree, Penni

The Remune HIV vaccine is likely to be authorized for marketing by Thai regulators, according to Immune Response.  The approval would be a boon to a company that has seen its cash resources and share price drop heavily since Pfizer pulled out of an alliance. Clinical studies in the United States have shown no clear benefit for the vaccine, and many scientists feel that Remune will not work as a standalone treatment.  The lead scientist in the vaccine's Thai trials is a major shareholder in the Trinity Medical Group, which has licensed Remune from Immune Response.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.